Bogdan Budnik

Dr. Bogdan Budnik

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2018 in Genome Biology
Verified
Journal Article
Open access
PDF file
BBBogdan Budnik
Bogdan Budnik
ELEzra Levy
Ezra Levy
GHGuillaume Harmange
Guillaume Harmange
NSNikolai Slavov
Nikolai Slavov
Some exciting biological questions require quantifying thousands of proteins in single cells. To achieve this goal, we develop Single Cell ProtEomics by Mass Spectrometry (SCoPE-MS) and validate its ability to identify distinct human cancer cell types based on their proteomes. We use SCoPE-MS to quantify over a thousand proteins in differentiating mouse embryonic stem cells. The single-cell proteomes enable us to deconstruct cell populations and infer protein abundance relationships. Comparison between single-cell proteomes and transcriptomes indicates coordinated mRNA and protein covariation, yet many genes exhibit functionally concerted and distinct regulatory patterns at the mRNA and the protein level.

20 August 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
BMBen M Maoz
Ben M Maoz
AHAnna Herland
Anna Herland
EFEdward A FitzGerald
Edward A FitzGerald
TGThomas Grevesse
Thomas Grevesse
CVCharles Vidoudez
Charles Vidoudez
KPKevin Kit Parker
Kevin Kit Parker

14 October 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
MYMoran Yadid
Moran Yadid
JLJohan U. Lind
Johan U. Lind
HAHerdeline Ann M. Ardoña
Herdeline Ann M. Ardoña
SSSean P. Sheehy
Sean P. Sheehy
LDLauren E. Dickinson
Lauren E. Dickinson
KPKevin Kit Parker
Kevin Kit Parker
Endothelial extracellular vesicles containing cardioprotective proteins rescue engineered human cardiac tissue in an ischemia-reperfusion injury model.

7 June 2023 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
RARushdy Ahmad
Rushdy Ahmad
BBBogdan Budnik
Bogdan Budnik
Single-cell methodologies and technologies have started a revolution in biology which until recently has primarily been limited to deep sequencing and imaging modalities. With the advent and subsequent torrid development of single-cell proteomics over the last 5 years, despite the fact that proteins cannot be amplified like transcripts, it has now become abundantly clear that it is a worthy complement to single-cell transcriptomics. In this review, we engage in an assessment of the current state of the art of single-cell proteomics including workflow, sample preparation techniques, instrumentation, and biological applications. We investigate the challenges associated with working with very small sample volumes and the acute need for robust statistical methods for data interpretation. We delve into what we believe is a promising future for biological research at single-cell resolution and highlight some of the exciting discoveries that already have been made using single-cell proteomics, including the identification of rare cell types, characterization of cellular heterogeneity, and investigation of signaling pathways and disease mechanisms. Finally, we acknowledge that there are a number of outstanding and pressing problems that the scientific community vested in advancing this technology needs to resolve. Of prime importance is the need to set standards so that this technology becomes widely accessible allowing novel discoveries to be easily verifiable. We conclude with a plea to solve these problems rapidly so that single-cell proteomics can be part of a robust, high-throughput, and scalable single-cell multi-omics platform that can be ubiquitously applied to elucidating deep biological insights into the diagnosis and treatment of all diseases that afflict us.

22 September 2022 in Science
Verified
Journal Article
Open access
SWSamuel J. Wattrus
Samuel J. Wattrus
MSMackenzie L. Smith
Mackenzie L. Smith
CRCecilia Pessoa Rodrigues
Cecilia Pessoa Rodrigues
EHElliott J. Hagedorn
Elliott J. Hagedorn
JKJi Wook Kim
Ji Wook Kim
LZLeonard I. Zon
Leonard I. Zon
Tissue-specific stem cells persist for a lifetime and can differentiate to maintain homeostasis or transform to initiate cancer. Despite their importance, there are no described quality assurance mechanisms for newly formed stem cells. We observed intimate and specific interactions between macrophages and nascent blood stem cells in zebrafish embryos. Macrophage interactions frequently led to either removal of cytoplasmic material and stem cell division or complete engulfment and stem cell death. Stressed stem cells were marked by surface Calreticulin, which stimulated macrophage interactions. Using cellular barcoding, we found that Calreticulin knock-down or embryonic macrophage depletion reduced the number of stem cell clones that established adult hematopoiesis. Our work supports a model in which embryonic macrophages determine hematopoietic clonality by monitoring stem cell quality.

29 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZIZohreh Izadifar
Zohreh Izadifar
JCJustin Cotton
Justin Cotton
SCSiyu Chen
Siyu Chen
VHViktor Horvath
Viktor Horvath
ASAnna Stejskalova
Anna Stejskalova
DIDonald E Ingber
Donald E Ingber
Modulation of the cervix by steroid hormones and commensal microbiome play a central role in the health of the female reproductive tract. Here we describe organ-on-a-chip (Organ Chip) models that recreate the human cervical epithelial-stromal interface with a functional epithelial barrier and production of mucus with biochemical and hormone-responsive properties similar to living cervix. When Cervix Chips are populated with optimal healthy versus dysbiotic microbial communities (dominated by Lactobacillus crispatus and Gardnerella vaginalis, respectively), significant differences in tissue innate immune responses, barrier function, cell viability, proteome, and mucus composition are observed that are similar to those seen in vivo. Thus, human Cervix Organ Chips represent physiologically relevant in vitro models to study cervix physiology and host-microbiome interactions, and hence may be used as a preclinical testbed for development of therapeutic interventions to enhance women’s health.